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Abstract 
Converging evidence has linked the anterior mid-cingulate cortex to negative affect, pain and 
cognitive control. Shackman and colleagues proposed this region uses information about 
punishment to control aversively motivated actions. Studies on the effects of lesions allow 
causal inferences about brain function; however, naturally occurring lesions in the anterior 
mid-cingulate cortex are rare.  In two studies we therefore recruited 94 volunteers, 
comprising 15 patients with treatment-resistant depression who had received bilateral 
Anterior Cingulotomy, which consists of lesions made within the anterior mid-cingulate 
cortex, 20 patients with treatment-resistant depression who had not received surgery and 59 
healthy controls. Using the Ekman 60 Faces paradigm and two Stroop paradigms, we tested 
the hypothesis that patients who received Anterior Cingulotomy were impaired in recognising 
negative facial affect expressions but not positive or neutral facial expressions, and impaired 
in Stroop cognitive control, with larger lesions being associated with more impairment. 
Consistent with hypotheses, we found that larger volume lesions predicted more impairment 
in recognising fear, disgust and anger, and no impairment in recognising facial expressions 
of surprise or happiness. However we found no impairment in recognising expressions of 
sadness.  Also consistent with hypotheses, we found that larger volume lesions predicted 
impaired Stroop cognitive control.  Notably, this relationship was only present when anterior 
mid-cingulate cortex lesion volume was defined as the overlap between cingulotomy lesion 
volume and Shackman and colleague’s meta-analysis derived binary masks for negative 
affect and cognitive control. Given substantial evidence from healthy subjects that the 
anterior mid-cingulate cortex is part of a network associated with the experience of negative 
affect and pain, engaging cognitive control processes for optimising behaviour in the 
presence of such stimuli, our findings support the assertion that this region has a causal role 
in these processes.  Whilst the clinical justification for cingulotomy is empirical and not 
theoretical, it is plausible that lesions within a brain region associated with the subjective 
experience of negative affect and pain may be therapeutic for patients with otherwise 
intractable mood, anxiety and pain syndromes. 
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Abbreviations:  
ACING: Anterior Cingulotomy 
aMCC: anterior mid-cingulate cortex 
CS: Classic Stroop 
EFS: Emotional Face Stroop task 
HAM-17: 17-item Hamilton Depression Rating Scale 
MADRS: Montgomery-Åsberg Depression Rating Scale 
HAD: Hospital Anxiety and Depression Scale 
NART: National Adult Reading Test 
MGH-S: Massachusetts General Hospital staging method 
ONA: lesion Overlap with Negative Affect mask 
OCC: lesion Overlap with Cognitive Control mask 
SPM: Statistical Parametric Mapping 
 
Introduction 
The anterior mid-cingulate cortex (aMCC) has been linked to cognitive control, negative 
affect and pain (Peyron et al., 2000, Vogt et al., 2003, Shackman et al., 2011).  Considering 
negative affect, a recent review of animal and human neuroimaging studies concluded that 
the aMCC represents negative values produced by a punisher or non-reward and neural 
activity correlates with subjective unpleasantness (Vogt, 2014).  Studies on the effects of 
lesions allow causal inferences about brain function.  However, as a consequence of the 
pattern of arterial supply to the aMCC, naturally occurring lesions confined to the aMCC are 
extremely rare (Rauch et al., 2000, Shackman et al., 2011).  We therefore investigated 
patients who received bilateral Anterior Cingulotomy (ACING), which consists of lesions in 
white matter deep to the aMCC (Rauch et al., 2000, Steele et al., 2008). 
Consistent with recent reviews of aMCC function in healthy humans (Shackman et al., 2011, 
Vogt, 2014), one of the earliest uses of ACING was to treat otherwise intractable pain, with 
an early study noting that patients with comorbid anxiety and/or depression appeared to 
have the best outcomes (Foltz and White, 1962).  ACING continues to be used for a small 
number of patients with intractable mood and/or obsessive compulsive disorder (OCD) 
(Rauch et al., 2000, Steele et al., 2008) and intractable pain (Pereira et al., 2014).  It is 
important to note that the ACING procedure differs significantly between centres with, for 
example, some centres using a single bilateral lesion which may be repeated after a year 
depending on clinical response (Steele et al., 2008), and other centres using three bilateral 
lesions on a single occasion (Yang et al., 2014).  In addition, the clinical indication (e.g. 
depressive illness, OCD or pain syndrome) differs complicating interpretation, as clinical 
syndromes such as mood disorder (Austin et al., 2001) and chronic pain (Schiltenwolf et al., 
2014) are associated with cognitive impairment independent of lesions.  Depressive illness, 
OCD and pain syndromes are highly comorbid, and neurosurgical comorbidity exclusion 
criteria are more clearly defined in some centres prior to neurosurgery (Steele et al., 2008) 
than others complicating interpretation of the literature. 
The current literature on the neuropsychological effects of ACING consists of single case or 
small studies, with some reporting impairments in cognitive and emotional functioning.  
Cohen described the neuropsychological effects of ACING for intractable pain (Cohen et al., 
1999) reporting deficits in sustained attention and response time.  Janer described ACING 
for mood disorder in one patient (Janer and Pardo, 1991) reporting selective attention 
deficits.  Ridout described four patients who had received ACING and five patients who had 
received a combination of Anterior Capsulotomy (ACAPS) and ACING (Ridout et al., 2007), 
reporting impaired Stroop performance and impaired identification of emotional expressions.  
In a further study, five patients had received ACING and three had received both ACAPS 
and ACING for depressive illness, had post-operative improvement in two tasks (Paired 
Associates Learning and Spatial Working Memory) and no impairment in any 
neuropsychological task, perhaps due to recovery from illness (Steele et al., 2008).  Ochsner 
described the effects of ACING in a single patient with OCD and Anorexia Nervosa (Ochsner 
et al., 2001) describing visual and attentional deficits. 
Therefore, whilst there have been reports of attentional impairments in patients with chronic 
pain after ACING (Cohen et al., 1999, Cohen et al., 1999), and general emotional 
recognition in a group of patients who had received both ACING and ACAPS (Ridout et al., 
2007), there is limited evidence for the effects of lesions only within the aMCC.  As there is 
considerable evidence for normal aMCC function being linked to negative affect and 
cognitive control (Shackman et al., 2011, Vogt, 2014), we predicted that lesions within the 
aMCC could result in specific impairments linked to these domains.  Notably, interpersonal 
deficits are not apparent clinically in our patients.  We were therefore predicting that more 
subtle impairments could be detected on neuropsychological testing.  In testing these 
predictions we considered it important to correct for residual illness severity at the time of 
testing and be anatomically specific about the location of the aMCC with regard to negative 
affect and cognitive control. 
Regarding anatomical specification of the aMCC, Shackman and colleague’s meta-analysis 
on studies of healthy subjects (Shackman et al., 2011) is notable because it was large, 
including data from 192 fMRI studies with more than 3000 participants, and the authors have 
made available binary maps for negative affect, pain and cognitive control 
(http://neurovault.org/collections/474/), explicitly defining the spatial extent of aMCC 
functional neuroanatomy in Montreal Neurological Institute (MNI) anatomical space.  We 
therefore used Shackman and colleague’s masks to define aMCC functional neuroanatomy.  
We chose the Ekman 60 faces paradigm as it’s a long established emotional recognition 
task and two Stroop paradigms. 
We tested two main a priori hypotheses and two tests for map specificity.  First, that 
increased volume of overlap between an ACING lesion and Shackman’s negative affect 
binary mask was associated with increased errors in recognising negative emotional 
expressions, but not positive or neutral expressions.  Second, we tested the hypothesis that 
increased volume of overlap between ACING lesions and Shackman’s cognitive control 
binary mask was associated with increased Stroop effect errors reflecting impaired cognitive 
control. 
ACING lesions are primarily made within white matter aiming for the cingulum bundle but 
also have significant anatomical effects on adjacent grey matter (Steele et al., 2008).  
Shackman’s anatomical masks were derived from a meta-analysis of fMRI studies of healthy 
subjects and most fMRI signal is generated by grey matter.  Neuropsychological 
impairments may be associated with grey matter, white matter or both.  To test this, our third 
hypothesis was that total lesion volume, involving both white and grey matter in contrast to 
grey matter linked volume defined by Shackman’s masks, would be associated with similar 
impairments as grey matter lesion volume alone. 
Finally, Shackman and colleagues argued that negative affect, pain and cognitive control 
activate an overlapping region, the aMCC (Shackman et al., 2011).  However, their negative 
affect and cognitive control masks are not identical and they acknowledged that further work 
was required to determine whether negative affect, pain and cognitive control are 
anatomically coincident or subtly different in spatial distribution (Shackman et al., 2011).  
Therefore, our fourth hypothesis was that we would find similar negative affect recognition 
and cognitive control deficits, regardless of which of the two masks were used to calculate 
lesion overlap volume. 
 
  
Materials and Methods 
Diagnosis was confirmed using the MINI PLUS (v5.0) (Sheehan et al., 1998) structured 
clinical interview and depressive illness severity quantified using the 17-item Hamilton 
Depression Rating Scale (HAM-17) (Hamilton, 1960), the Montgomery-Åsberg Depression 
Rating Scale (MADRS) (Montgomery & Asberg, 1979) and the anxiety subscale of the 
Hospital Anxiety and Depression (HAD) (Zigmond and Snaith, 1983) scale.  Quality of life 
was assessed using the SF-36, a generic scale designed to assess aspects of health and 
well-being which are not disease, treatment or age specific, consisting of eight multi-item 
components (Juenger et al., 2002).  Here the eight components were averaged to give a 
single SF-36 score.   IQ was estimated using the National Adult Reading Test (NART) and 
mood disorder treatment-resistance quantified using the Massachusetts General Hospital 
Staging (MGH-S) method (Fava, 2003).  The study was approved by the local ethics 
committee and written informed consent obtained from participants. 
ACING is a long established neurosurgical stereotactic procedure for chronic treatment-
refractory depressive illness, offered in the UK only when all other reasonable treatment 
strategies have failed, when the patient requests the operation, provided they are capable of 
informed consent (Steele et al., 2008).  In Scotland, the suitability of and capacity to consent 
to the procedure is confirmed independently by medical and lay representatives of the 
Mental Welfare Commission with the Care Quality Commission undertaking a similar 
function in England.  Patients who had received ACING for treatment-resistant depression 
were recruited from the Advanced Interventions Centre (AIS) in Dundee, an NHS UK-wide 
tertiary referral centre for treatment-resistant depression.  Patients had received a single 
bilateral ACING lesion on at least one occasion as described (Steele et al., 2008) with 
approximately half the remaining patients receiving two bilateral lesions and one patient 
three bilateral lesions. 
The emotional facial recognition task data was collected as part of a long term ongoing 
longitudinal study (Study 1) on the neuropsychological assessment of patients receiving 
ACING.  Twelve ACING patients participated (surgical patient group 1, SPG1). The control 
data consisted of thirty-eight participants (control group 1, CG1) without a history of mood 
disorder.  Study 1 began over a decade ago.  However some time ago we found that staff 
had stopped collecting Stroop data.  Stroop data was therefore collected as part of a 
separate cross-sectional study (Study 2).  Eight patients who had received one or more 
ACING procedures, and no other neurosurgical procedure (e.g. ACAPS), participated in 
Stroop testing (patient group 2, SPG2).  In addition, we recruited a separate group of twenty 
patients with treatment-resistant depressive illness who had not received neurosurgery (non-
surgical patient group 2, NSPG2).  We also recruited a further group of twenty-one controls 
(control group 2, CG2) as CG1 volunteers had not participated in Stroop testing. Fifteen 
ACING patients participated in total with five taking part in both studies.  We therefore 
included data from ninety four unique subjects in the analyses.  We collected other 
neuropsychological data in both studies using the CANTAB (Cambridge Cognition Ltd) which 
will be reported elsewhere. 
Recruitment of patients from the AIS who had received ACING meant that patients satisfied 
the following criteria at the time of neurosurgery (Steele et al., 2008): diagnosis of F32.2 
severe depressive episode without psychotic symptoms; F32.3 severe depressive episode 
with psychotic symptoms; F33.1 to F33.3 recurrent depressive disorder current episode 
moderate to severe; F31.4 to F31.5 bipolar affective disorder, current episode severe 
depression with or without psychotic symptoms.  The patient had to be capable of providing 
sustained informed consent. The criteria for exclusion were a current diagnosis of substance 
misuse fulfilling criteria for ICD-10 F10 to F19 mental and behavioural disorders due to 
psychoactive substance use, a diagnosis of organic brain syndrome fulfilling criteria for ICD-
10 F00 to F09 including Alzheimer’s disease, vascular and other dementias, a diagnosis of 
Adult Personality Disorder fulfilling criteria for ICD-10 F60 to F69, and a diagnosis of 
Pervasive Developmental Disorder fulfilling criteria for ICD-10 F84. 
Non-surgical patients with depressive illness satisfied similar criteria and controls were 
matched on the basis of age, male/female ratio and NART.  These patients were also 
recruited from the AIS and included patients who later proceeded to ACING plus others in 
long term follow-up by secondary care Community Mental Health Care (CMHT) services.  As 
is typical for patients with treatment-resistant mood disorder attending the AIS, patients 
almost always had one episode of illness, which they had suffered from for decades, with 
incomplete recovery despite multiple treatment trials.  Non-surgical patients were matched to 
patients receiving ACING (Study 2) on the basis of medication exposure using the MGH-S.  
Controls were recruited from friends and relatives of patients.  Advertisement was not used 
for recruitment.  No subjects had co-morbid pain syndromes. 
Study 1 - Emotional Facial Recognition Task 
A test from the Facial Expressions of Emotion: Stimuli and Tests (FEEST) was used to 
assess the ability to recognise facial expressions of emotions (Young et al., 2002).  The 
Ekman 60 Faces (E60F) (Fig. 1) test uses photographs of the faces of ten people from the 
Ekman series (Ekman & Friesen, 1976). For each face, there are facial expressions of six 
basic emotions: happiness, surprise, fear, sadness, disgust and anger, giving a total of sixty 
pictures with ten for each emotion. Negative affect expressions were defined as fear, 
disgust, anger and sadness; positive or neutral expressions as happiness and surprise. 
Study 2 - Stroop Tasks 
Two versions of the Stroop task were used, an emotionally neutral colour naming Stroop 
task (Classic Stroop, CS) and an Emotional Face Stroop task (EFS) (Fig. 1).  The CS task 
involves naming the colour of the ink (e.g. red or blue) that a colour word (‘red’ or ‘blue’) is 
written in. Congruent trials consist of the word being written in the same colour of ink, 
incongruent trials with the word written in a different colour of ink. In incongruent trials, 
interference between the word and ink colour results in increased errors and reaction times 
(Stroop, 1935). 
Different ‘emotional’ versions of the Stroop exist.  In one of the commonest types, slower 
naming of the colour an emotional word is written in (e.g. ‘war’, ‘kill’) occurs, involving an 
effect of the emotional relevance of the word, but without a conflict with word meaning. We 
wished to use a version of the Stroop which does involve an explicit conflict with meaning, 
analogous to the CS task. Therefore the EFS task we chose involved incongruent trials (e.g. 
picture of a sad face and the word ‘happy’ underneath) and congruent trials (e.g. picture of a 
sad face and the word ‘sad’ underneath) (Saunders & Jentzsch, 2014). Incongruent trials, 
requiring increased cognitive control to minimise errors, tend to activate the aMCC 
(Shackman et al., 2011). The ‘Stroop effect’ was defined for both CS and EFS tasks as the 
difference in the total number of errors: [incongruent – congruent] conditions. 
Neuroimaging 
For each participant structural T2 weighted brain scans were acquired at least a year after 
ACING when radiological appearances are stable with lesions quantified using the method 
we described previously (Steele, Christmas, Eljamel, & Matthews, 2008).  Briefly, each T2 
weighted image was segmented into separate grey and white matter and cerebrospinal fluid 
(CSF) images and spatially normalised to Montreal Neurological Institute (MNI) anatomical 
space using SPM8 (Friston et al., 2007). In T2 weighted images, ACING lesions have a 
voxel intensity corresponding to CSF. For each subject and blind to outcome using MRIcron 
(http://www.mccauslandcenter.sc.edu/mricro/mricron/), the spatially normalised and 
segmented CSF images were viewed in transverse section.  ACING lesions were outlined in 
each hemisphere and a list of voxel coordinates in MNI space obtained at 1 mm spacing, 
defining each lesion volume in cubic millimetres (Steele et al., 2008). For each subject, 
lesion volume was visualised using MRIcron and the overlap between each binary map 
(cognitive control or negative affect) and lesion volume was output as a list of voxel 
coordinates in MNI space, with overlap volume being the total number of coordinates 
multiplied by the voxel volume.  Cognitive control and negative affect binary masks, lesion 
volumes and overlap regions are shown for representative subjects in Fig. 1. 
Analyses - Study 1 - Emotional Facial Recognition Task 
Between groups: For patients (SPG1), the total number of errors in detecting each of the six 
emotions was compared to controls (CG1) and the null hypothesis of no difference tested 
using t-tests.  This calculation was done for both pre-operative baseline and post-operative 
follow up assessment. 
First a priori hypothesis: For each of the six emotions, a linear regression was calculated 
with the volume of overlap (between each patient’s lesions and Shackman’s negative affect 
binary mask) as the dependent variable (overlap negative affect, ONA), and number of 
emotion recognition errors as the first independent variable, depressive illness severity at the 
time of testing (MADRS or HAM-17) as the second independent variable and number of 
ACING procedures as the third independent variable.  These covariates were included as 
both illness severity and number of operations correlated with total emotion recognition 
errors. 
Analyses - Study 2 - Stroop Tasks 
Between groups: For patients (SPG2), Stroop effect total errors for the CS and EFS tasks 
were tested using an ANOVA with the main effects group (SPG2, NSPG2 and control) and 
task type (CS vs EFS) and their interaction with covariates MADRS, HAM-17, HAD-A and 
number of ACING operations. 
Second a priori hypothesis: A linear regression was done with the volume of overlap 
(between each patient’s lesions and Shackman’s cognitive control binary mask) as the 
dependent variable (overlap cognitive control, OCC), and the total CS and EFS Stroop effect 
error rate as the first independent variable, depressive illness severity (MADRS or HAM-17) 
as the second independent variable and number of ACING procedures as the third 
independent variable. 
Specificity of Shackman masks 
Third hypothesis: This was tested with linear regressions as above, but with total lesion 
volume as the dependent variable. 
Fourth hypothesis: This was tested with total volume of overlap (between each patient’s 
ACING lesion and the cognitive control binary mask, OCC) as the dependent variable, and 
the total number of facial recognition errors as the first independent variable, depressive 
illness severity (MADRS or HAM-17) as the second independent variable and number of 
ACING procedures as the third independent variable. We also tested whether the total 
volume of overlap (between each patient’s ACING and the negative affect binary mask, 
ONA) was significantly related to the total number of Stroop errors, taking account of 
depressive illness severity (MADRS or HAM-17) and number of ACING procedures. 
Correction for post hoc testing 
We only had two a priori regions of interest (ROI) per patient: overlaps between Shackman’s 
masks (negative affect and cognitive control) and ACING lesion.  In addition we only had 
one strong a priori hypothesis for each ROI based on the cited literature.  In Study 1 we had 
no specific hypotheses about any individual emotion and instead we had one a priori 
hypothesis about negatively valenced emotions in general.  We did not draw conclusions 
about any specific emotion.  In Study 2 we similarly only had one a priori hypothesis about 
increased Stroop errors.  Consequently, we did not use post hoc correction for linear 
regression testing of the two a priori hypotheses. It was possible to apply correction to the 
third and fourth hypotheses but this was not done to have a low threshold for detecting non-
specificity of the masks.  Other tests had less a priori basis so Bonferroni correction was 
applied. 
 
  
Results 
Participants 
Groups were matched on the bases of male/female ratio, age and NART. In Study 1, there 
were no significant differences in male/female ratio (Chisq=1.7, p=0.19), age (t=0.13, 
p=0.89) or NART (t=1.5, p=0.1). Similarly, in Study 2 there were no significant differences in 
male/female ratio (Chisq=2.1, p=0.3), age (F=1.6, p=0.2) or NART (F=0.3, p=0.7). 
As shown in Table 1, MGH-S scores of 15.9 to 17.3 for patients receiving ACING indicated a 
very high level of treatment-resistance, similar to previous studies of patients attending the 
AIS (15.6) (Steele et al., 2008), in contrast to much less treatment-resistant secondary care 
6.9 and primary care patients 0.54 (Hazari et al., 2013).  SF-36 ratings (30±12 and 44±15) 
indicated marked quality of life impairments in patients with treatment-resistant depression 
before surgery (SPG1) (Table 1). 
Patients satisfied ICD 10 criteria for recurrent unipolar depressive disorder unless in 
remission.  With ACING ‘response’ defined as a reduction of 50% or more at one year 
compared to baseline HAM-17 and MADRS scores (Steele et al., 2008), ACING responders 
(n=6 Study 1, n=5 Study 2) had SF-36 scores of 60±13 and 88±10 respectively and non-
responders (n=6 Study 1, n=3 Study 2) 31±14 and 35±20 respectively.  Combined responder 
and non-responder scores are shown in Table 1.  These scores can be compared with other 
severe chronic illnesses: 72, 55, 36 for congestive heart failure (New York Heart Association, 
NYHA, classes 1, 2, 3 respectively), 62 for hepatitis and in addition, 51 for non-treatment 
resistant depression with 89 for controls (Juenger et al., 2002). 
Analyses - Study 1 - Emotional Facial Recognition Task 
Pre-operative baseline and follow-up illness severity (MADRS, HAM-17, HAD-A) plus 
estimated IQ (NART) are shown in Table 1.  This indicates that patients had a depressive 
illness in the ‘moderate-severe’ range before their operation and illness severity had on 
average decreased significantly at long term follow up (MADRS, t=3.04, p=0.014, HAM-17, 
t=2.5, p=0.02).  There was no significant change in estimated IQ. 
Between groups’ analyses: The average number of errors made by subjects (standard 
deviation in brackets) for recognition of different emotions is shown in Table 2.  In 
comparison to controls, at pre-operative baseline, patients made significantly more errors in 
recognising expressions of disgust (t=2.2, p=0.01) but not any other emotions (t=1.6, 
p>0.05).  In contrast and in comparison to controls, patients at follow-up made significantly 
more errors in recognising expressions of fear (t=1.6, p=0.004) but no other emotions 
(p>0.05). Only post-operative impairment in fear recognition remained significant after 
Bonferroni correction (p=0.048). 
Within patient group correlations: As depressive illness can be associated with cognitive 
impairment, we did exploratory tests for correlations between errors in recognising different 
emotional expressions and illness severity at baseline and follow-up.  At pre-operative 
baseline, fear, anger and disgust recognition errors correlated positively with HAM-17 illness 
severity (r= 0.62, p=0.05; r=0.74, p=0.01; r=0.67, p=0.05 respectively). At follow-up, HAM-17 
and MADRS also correlated positively with anger recognition errors (r=0.63, p= 0.05; r=0.58, 
p= 0.05). There were no significant correlations with anxiety (HAD-A) scores.  There was a 
positive correlation between increased fear recognition errors and number of ACING 
procedures (r=0.78, p=0.02).  There were no correlations with NART IQ score at either 
baseline or follow up. 
First a priori hypothesis:  When illness severity (quantified by either MADRS or HAM-17) and 
number of ACING procedures were ‘covaried out’, there was a significant relationship (Table 
3) between ONA and impairment in identifying negative emotions of fear, disgust and anger, 
but not sadness, and no relationship between overlap and expressions of happiness or 
surprise.  Bonferroni correction was not used as these were a priori planned tests.  Fig. 2 
shows partial regression plots for ONA versus total errors for fear, disgust and anger. 
Analyses - Study 2 - Stroop Tasks 
Clinical and demographic details for controls (CG2), patients with depression who had not 
received ACING (NSPG2), and patients who had received ACING as treatment (SPG2), are 
shown in Table 1. 
There was a significant main effect of group with regard to MADRS (F=28.9, p<0.001), HAM-
17 (F=30.5, p<0.001), HAD-A (F=26.1, p<0.001) but not NART (F=0.6, p=0.55). Post-hoc 
pair wise comparisons after Bonferroni correction revealed significant differences in: a) 
MADRS scores between the SPG2 and CG2 (p<0.001), and between the non-surgical 
depression group (NSPG2) and CG2 (p<0.001); b) HAM-17 scores between SPG2 and CG2 
(p<0.001) and between the NSPG2 group and CG2 (p<0.001); c) HAD-A scores HAM-17 
scores between the SPG2 and CG2 (p<0.001) and between NSPG2and CG2 (p<0.001).  No 
interaction was found for type of task (p=0.8) therefore CS and EFS data were pooled.  
This indicates that patients with depressive illness who had received ACING had less 
depressive symptoms than those who had not and there were no significant differences in IQ 
between groups. 
Between groups’ analyses: There was a significant effect of group on Stroop effect errors 
(F=4.4, p=0.017) and post-hoc pair-wise testing with Bonferroni correction identified 
significant differences between SPG2, NSPG2 and CG2 (p=0.013).  There was also a 
significant effect of Stroop effect on reaction time (F=3.7, p=0.032). 
Within SPG2 group correlations: Linear regressions were used to test for a relationship 
between Stroop effect errors and symptom severity scores in the SPG2 group alone. Stroop 
effect errors correlated significantly with MADRS (t=2.7, p=0.018), HAM-17 (t=5.9, p=0.001) 
and HAD-A (t=2.9, p=0.023) scores.  This indicates that more ill patients made more Stroop 
effect errors. There was no relationship with number of ACING procedures (t=1.4, p=0.2). 
Second a priori hypothesis: Similar to emotional facial recognition, we tested the hypothesis 
of a significant positive relationship between OCC and total Stroop errors, taking account of 
illness severity and number of operations.  There was a significant positive relationship 
between cognitive control mask overlap and Stroop effect errors ( β =1.2, p=0.03) as shown 
in Fig. 2. 
Specificity of masks 
Third hypothesis: We tested whether lesion volume was significantly associated with 
emotional facial expression recognition accuracy or Stroop task accuracy, taking into 
account illness severity and number of ACING procedure. There were no significant 
correlations between total lesion volume and recognition of fear (r =-1.6, p=0.15), disgust (r 
=0.3, p=0.78), anger (r=-1.56, p=0.16), sadness (r=-0.198, p=0.85), surprise (r=-0.83, 
p=0.43) or happiness (r=0.75, p=0.48). Similarly, there were no significant correlations 
between total lesion volume and Stroop effect errors (r =2.2, p=0.09).  This indicates that 
total lesion volume, which includes both grey and white matter, was not systematically 
related to impairments in emotional facial recognition or cognitive control. 
Fourth hypothesis: There was no relationship between OCC and any other emotions, such 
as fear (r=3.6, P=0.1), disgust (r =0.5, p=0.7), anger (r=0.09, p=0.5), sadness (r=0.02, 
p=0.96), surprise (r=-0.3, p=0.4) and happiness (r=0.4, p=0.15). Similarly, there was no 
significant correlation between ONA and Stroop effect errors (r=4.2, p=0.4).  This indicates 
that small differences between the negative affect and cognitive control masks were 
important for predicting the observed impairments. 
 
  
Discussion 
Negative affect, cognitive control and pain have been strongly linked to the aMCC (Peyron et 
al., 2000, Shackman et al., 2011, Vogt, 2014).  Clinically, ACING lesions within the aMCC, 
have long been used as treatment for otherwise treatment-resistant mood and anxiety 
disorders (e.g. OCD) (Dougherty et al., 2002, Steele et al., 2008) and chronic pain 
syndromes (Pereira et al., 2014). 
Consistent with our hypotheses, we found that increased volume of overlap between ACING 
lesions and the negative affect map (ONA) predicted impaired recognition of negative 
emotions of fear, disgust and anger and no impairment in recognising facial expressions of 
surprise or happiness.  In addition, we found that increased volume of overlap between 
ACING lesions and the cognitive control map predicted increased Stroop effect errors.  Only 
the overlap between ACING lesions and the negative affect map was associated with 
impairments in recognising facial expressions of negative affect and Stroop effect errors, not 
total ACING lesion volume or when using the cognitive control mask, supporting the 
specificity of Shackman’s grey matter-linked map functions. 
Contrary to predictions, we did not find that ONA was associated with impaired accuracy in 
identifying emotional expressions of sadness.  However, Vogt highlighted fear and pain as 
being particularly associated with aMCC function, but not sadness, which he linked to the 
subgenual cingulate region (Vogt et al., 2003).  Our results support the suggestion that the 
aMCC is less directly associated with sadness than other negative emotions such as fear. 
Extensive cross-species data links the amygdala to the acquisition and expression of 
conditioned fear, with rodent studies also implicating the prelimbic region of the medial 
frontal cortex which is homologous with the aMCC in humans (Milad et al., 2007).  The 
aMCC projects to the amygdala (Vogt, 2009) with these projections being excitatory (Brinley-
Reed et al., 1995).  In humans, the aMCC was reported to be activated by a conditioned fear 
stimulus with aMCC cortical thickness being positively correlated with skin conductance 
response during aversive electrical shock conditioning (Milad et al., 2007).  Notably, the 
aMCC also projects directly to the Peri-Aqueductal Grey (PAG) (Vogt, 2009) which is 
strongly associated with pain and fear (Graeff, 2004).  Patients receiving ACING in Study 1 
were significantly impaired in recognising facial expressions of fear.  Further supporting a 
link between the aMCC and fear, recently it has been reported that transient electrical 
stimulation of the most anterior part of the aMCC (MNI coordinate system, anterior-posterior 
range y = 20-26) was associated with induced feelings of ‘shakiness’ and ‘a sense of 
“challenge” or “worry” (also known as foreboding)’ and ‘feeling worried and anxious that 
something negative was going to happen’ (Parvizi et al., 2013).  In contrast, more posterior 
(MNI y = 0-18) aMCC transient electrical stimulation was reported to induce ‘complex’, 
‘stereotyped’ behaviours, ‘invariably involuntary, sometimes the subject was able to resist 
performing them, sometimes not’, but usually without clear effects on emotion (Talairach et 
al., 1973).  Talairach’s description of induced behaviours is reminiscent of compulsions 
occurring in Obsessive Compulsive Disorder (OCD) and ACING is also used to treat 
otherwise intractable OCD.  The anterior vs. posterior MCC stimulation effects are consistent 
with reports of the anterior but not the posterior MCC being associated with emotion (Vogt et 
al., 2003). 
Theoretical accounts of the MCC have considered whether this structure is simply involved 
in detecting conflict or whether it resolves and controls conflict.  Shackman and colleagues 
proposed that the aMCC processes both punishment-linked information and facilitates 
actions which avoid future punishment (Shackman et al., 2011).  They formulated this as the 
Adaptive Control Hypothesis (ACH) noting that negative affect, anxiety and pain tend to 
engage the same processes described by theories of cognitive control to resolve similar 
challenges (Shackman et al., 2011).  In particular, cognitive control tends to be engaged 
when habitual responses are insufficient to allow goal directed behaviour, particularly when 
there is uncertainty and conflict about the optimal course of action.  Notably, studies on 
patients receiving ACING for treatment-resistant psychiatric disorders have reported 
individual neurones in the aMCC encoding response conflict information (Davis et al., 2005, 
Sheth et al., 2012) and individual neuronal firing that was predictive of motor actions 
(Williams et al., 2004).  This and the results of the present study suggests that the MCC is 
involved in resolution and control of conflict supporting the ACH. 
Behavioural errors are associated with an electrophysiological event-related potential, the 
Error Related Negativity (ERN). This signal is thought to reflect a discrepancy between 
representations of actual and correct actions and the ERN has been linked to MCC function 
(Riesel et al., 2013, Cavanagh and Shackman, 2015).  The ERN was reported to be 
abnormally reduced in a patient with a rare naturally occurring lesion of the MCC (Swick and 
Turken, 2002).  A recent review concluded that the ERN is abnormally increased in OCD, 
depression and generalised anxiety disorder, and an increased ERN is associated with high 
trait anxiety and high negative affect (Weinberg et al., 2012). 
The ERN is one of several MCC-related behavioural control signals, and spectral 
decomposition has shown that the ERN, the ‘Feedback Related Negativity’ which is linked to 
punishment, and the ‘N2’ which is linked to conflict, share a common component in the theta 
band of the electroencephalogram (Cavanagh and Shackman, 2015). It has been proposed 
that frontal midline theta signals reflect MCC activity, being part of the neural mechanism for 
optimally adjusting behaviour to uncertainty, a characteristic of events that cause anxiety 
and require cognitive control (Cavanagh and Shackman, 2015).  Recently a large 
international study has concluded that patients with depressive illness have abnormally 
increased frontal and rostral anterior cingulate theta compared to controls, which the authors 
suggest is a potential endophenotype of depressive illness (Arns et al., 2015). 
Consequently, there is convergent evidence that the aMCC is an important part of a network 
linked to the experience of negative affect which engages cognitive control processes for 
optimising behaviour.  In this context, our finding that increased lesion volume was linked to 
increased impairment in recognising facial expressions of negative affect, but not positive or 
neutral affect, and impairment in Stroop cognitive control, supports the assertion that the 
aMCC has a causal role in these processes.  Importantly though, these abnormalities were 
only detectable on neuropsychological testing and not clinically.  The therapeutic benefit of a 
reduction in negative affect may be associated with a reduction in cognitive control.  
However depressive illness has been reported to be associated with Stroop impairments 
independent of any lesion and we found correlations with illness severity in the present 
study.  Therefore with ACING it is possible that any reduction in cognitive control is offset by 
an improvement in mood.  Before receiving ACING, patients were ill long-term, highly 
treatment-resistant and had an SF-36 measured quality of life comparable to patients with 
very disabling diseases.  AIS patients with treatment-resistant depression typically have an 
ACING ‘response’ rate of 62% (Steele et al., 2008) and for those who responded, this was 
associated with a substantially improved quality of life.  Further work on understanding the 
normal function of the aMCC, and abnormal function in depressive illness, may allow the 
development of improved surgical techniques and outcomes. 
A possible limitation is the small number of subjects.  ACING is however a treatment of last 
resort, done in a limited number of centres world-wide, so the number of patients available 
for testing is limited.  Furthermore, recruitment criteria and ACING procedures differ between 
centres complicating independent replication.  To our knowledge we report data on more 
patients who have received ACING than previously.  Medication exposure, quantified using 
the MGH-S score, has potential limitations.  It’s not known if different medications given long 
term and in combination have different effects on facial affect recognition independent of 
illness severity in treatment-resistant illness. 
In summary, it has been proposed that the aMCC is linked to the experience of negative 
affect and cognitive control (Shackman et al., 2011, Vogt, 2014).  As hypothesised, we found 
that aMCC overlap volume was linked to impaired recognition of facial expressions of 
negative affect, in particular fear, disgust and anger, but not positive or neutral emotions.  
Also as hypothesised, the aMCC overlap volume was significantly related to impaired 
performance on Stroop tasks reflecting impaired cognitive control.  Whilst the clinical 
justification for ACING is empirical and not theoretical, it is plausible that lesions within a 
brain region associated with the subjective experience of negative affect and pain 
(Shackman et al., 2011, Vogt, 2014) may be therapeutic for patients with otherwise 
intractable mood, anxiety and pain syndromes. 
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Table 1. Demographic and clinical characteristics   
SPG1: Surgical Patient Group 1, CG1: Control Group1, SPG2: Surgical Patient Group 2, 
CG2: Control Group, NSP: Non-Surgical Patients 2. Values are mean (standard deviation); 
NART, National Adult Reading Test; MADRS, Montgomery-Asberg Depression Rating 
Scale; HAM-17, Hamilton Depression Rating Scale; HAD-A, Hospital anxiety and depression 
scale; Massachusetts General Hospital Staging (MGH-S), not significant (NS), not applicable 
(N/A), not available (-) 
 
 
 
 
 
 
 
 
 
 CG1 SPG1 
Baseline 
SPG1 
Follow-up 
CG2 NSPG2 SPG2 
Age 
(years) 
50.9 
(8.3) 
50.63 
(5.0) 
51.63 (5.0) 46.1 (14) 51.80 (11.23) 53.1 (7.4) 
Male/ 
Female 
14/24 2/10 2/10 6/15 5/15 0/8 
NART 121.7 
(5.7) 
117.6 
(7.4) 
118.6 (7.8) 122.8 
(5.8) 
122.75 (4.7) 124.4 (5.2) 
MADRS - 42.25 
(5.9) 
28.58 (16.7) 0.48 
(1.03) 
22.50 (7.97) 17.13 (16.7) 
HAM-17 - 27.9 (4.9) 19.7 (10.5) 1.3 (1.5) 16.10 (5.58) 15.9 (7.8) 
HAD-A - 13.1 (4.7) 11.33 (6.5) 8.8 (6.8) 11.05 (3.9) 8.4 (6.8) 
MGH-S N/A 16.3 (3.5) 16.3 (3.5) N/A 13.24 (10.78) 15.3 (1.98) 
SF-36 - 30.1(12.3) 45.6 (20.1) 93.5(4.0) 44.2(14.9) 55.4(33) 
  
Table 2. Errors on Emotional Facial Recognition and Stroop tasks. 
Values are mean (standard deviation), not available (-) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CG1 SPG1 SPG2 CG2 NSPG2 SPG2 
Fear 2.76 (2) 3 (2.5) 4.3 (2.4) - - - 
Disgust 1.05 (1.3) 2.1 (1.2) 2.2 (1.8) - - - 
Anger 1.89 (7.8) 2.2 (1.9) 2.2 (2) - - - 
Sadness 1.97 (4.6) 2 (1.1) 2.1 (1.5) - - - 
Surprise 1.16 (1.1) 1 (1.7) 1.5 (1.6) - - - 
Happiness 0.01 (0.3) 0.2 (0.4) 0 (0) - - - 
Stroop effect 
errors 
- - - 8.2 (5.9) 13.7 
(6.6) 
20.27 
(20.4) 
Stroop effect 
reaction time 
- - - 51.15 
(35.1) 
92.10 
(67.2) 
100.3 
(72.25) 
  
Table 3 Emotional facial recognition lesion overlap. 
Regression parameters ( β ), significance (Sig.) 
 
 
 
 
 
 
 
 
 
 
 
  MADRS  HAMD Num. of Procedure 
 
Errors 
 
 
β  
 
Sig. 
 
β  
MADRS 
 
Sig. 
 
  β  
HAMD 
 
Sig. 
 
β Num. of 
Procedure 
 
 
Sig. 
fear 0.6 0.03* 0.5 0.6 - - 0.5 0.07 
 0.5 0.02* - - 0.6 0.02* 0.3 0.1 
disgust -0.7 0.02* 0.09 0.7 - - 0.7 0.02* 
 -0.6 0.036* - - 0.2 0.4 0.6 0.05* 
anger 0.6 0.02* 0.07 0.8 - - 0.5 0.05* 
 0.1 0.035* - - 0.2 0.4 0.4 0.08 
sadness -0.02 0.96 0.4 0.3 - - 0.4 0.2 
 -0.4 0.2 - - 0.5 0.07 0.5 0.1 
happiness 0.4 0.15 0.4 0.2 - - 0.4 0.2 
 0.4 0.13 - - 0.5 0.08 0.3 0.3 
surprise -0.3 0.4 0.4 0.2 - - 0.3 0.3 
 -0.3 0.2 - - 0.4 0.1 0.4 0.2 


